Unlock stock picks and a broker-level newsfeed that powers Wall Street.
43.01
+3.41
+(8.61%)
At close: 4:00:01 PM EDT
43.06
+0.05
+(0.12%)
After hours: 4:29:30 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 15 | 15 |
| Avg. Estimate | -1.08 | -1.1 | -4.29 | -4.21 |
| Low Estimate | -1.36 | -1.36 | -6.37 | -6.57 |
| High Estimate | -0.86 | -0.85 | -2.17 | -1.75 |
| Year Ago EPS | -0.59 | -0.81 | -3.35 | -4.29 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 17 | 17 |
| Avg. Estimate | 6.91M | 11.16M | 39.91M | 64.35M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 10.37M | 60M | 90M | 321.9M |
| Year Ago Sales | 7.89M | 7.33M | 36.13M | 39.91M |
| Sales Growth (year/est) | -12.45% | 52.14% | 10.46% | 61.24% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.8 | -0.75 | -0.85 | -0.9 |
| EPS Actual | -0.59 | -0.81 | -1.46 | -0.49 |
| Difference | 0.21 | -0.06 | -0.61 | 0.41 |
| Surprise % | 26.39% | -8.18% | -72.22% | 45.69% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.08 | -1.1 | -4.29 | -4.21 |
| 7 Days Ago | -1.07 | -1.08 | -4.27 | -4.22 |
| 30 Days Ago | -0.96 | -1.01 | -3.83 | -3.83 |
| 60 Days Ago | -0.94 | -1 | -3.78 | -3.74 |
| 90 Days Ago | -0.94 | -1 | -3.78 | -3.74 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 2 | -- | -- |
| Up Last 30 Days | 1 | 2 | 5 | 4 |
| Down Last 7 Days | 1 | 6 | 2 | 1 |
| Down Last 30 Days | 7 | 6 | 11 | 10 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MRUS | -82.91% | -35.35% | -28.05% | 1.97% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Reiterates | Guggenheim: Buy to Buy | 3/28/2025 |
| Reiterates | Guggenheim: Buy to Buy | 3/18/2025 |
| Maintains | B of A Securities: Buy to Buy | 3/10/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/3/2025 |
| Maintains | Needham: Buy to Buy | 2/28/2025 |
| Initiated | Piper Sandler: Overweight | 2/13/2025 |
Related Tickers
MLTX MoonLake Immunotherapeutics
38.05
+4.68%
RVMD Revolution Medicines, Inc.
34.60
+2.91%
ACLX Arcellx, Inc.
67.23
+10.76%
APGE Apogee Therapeutics, Inc.
37.83
+6.23%
CNTA Centessa Pharmaceuticals plc
13.70
+3.55%
BCYC Bicycle Therapeutics plc
8.05
+2.55%
PTGX Protagonist Therapeutics, Inc.
48.20
+2.82%
RYTM Rhythm Pharmaceuticals, Inc.
51.96
+3.92%
CRNX Crinetics Pharmaceuticals, Inc.
31.39
+2.51%
SRRK Scholar Rock Holding Corporation
32.54
+8.25%